May 8, 2024 /
In Phase 2 trials, drinkable medication with gold nanocrystals significantly reduced symptoms
By Melissa Rudy Fox News – Published April 30, 2024 5:30am EDT
Researchers may have hit “gold” when it comes to the treatment of multiple sclerosis.
An experimental medication called CNM-Au8 — a drinkable liquid with gold nanocrystals — has shown promising results in clinical trials in terms of improvements in MS symptoms.
The “catalytically active” liquid, developed by Clene Nanomedicine in North East, Maryland, can cross the blood-brain barrier to help improve cellular energy and restore neurological function, according to researchers.
Doctors at the University of Sydney presented the Phase 2 clinical trial findings at the American Academy of Neurology’s annual meeting earlier in April 2024.
The clinical trials included 78 patients who had relapsing multiple sclerosis.
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY
